Streetbeat News

Earnings

MBIO

Mustang Bio reported Q2 losses of $(2.00) per share, a 29.82% improvement from $(2.85) per share losses in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:49 pm

FBIO

Fortress Biotech (NASDAQ:FBIO) reported Q2 losses of $(0.07) per share, a 30% improvement from $(0.10) per share YoY. However, sales decreased by 7.94% to $17.39 million from $18.89 million YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:48 pm

SCYX

SCYNEXIS (NASDAQ:SCYX) reported Q2 earnings of $2.46 per share, beating the analyst consensus estimate of $1.55 by 58.71%. This is a 893.55% increase from the same period last year. The company also reported quarterly sales of $131.50 million, beating the analyst consensus estimate of $95.45 million by 37.77%. This is a 9.84K% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:48 pm

DMAC

DiaMedica Therapeutics reported Q2 losses of $(0.16) per share, beating the analyst consensus estimate of $(0.18) by 11.11%. However, this is a 23.08% decrease over losses of $(0.13) per share from the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 14, 2023 | 8:48 pm

GETY

Getty Images Holdings, Inc. (NYSE:GETY) reported disappointing Q2 results, with losses of 1 cent per share, missing the analyst consensus estimate of positive 4 cents. Quarterly sales were $225.68 million, missing the analyst consensus estimate of $235.64 million. However, the company raised its full-year 2023 revenue guidance. The stock is also a top short squeeze candidate this week.

Portfolio Pulse from Ryan Gustafson

August 14, 2023 | 8:47 pm

NRXP

NRX Pharmaceuticals reported Q2 losses of $(0.12) per share, beating the analyst consensus estimate of $(0.14) by 14.29%. However, this represents a 9.09% increase in losses compared to the same period last year.

Portfolio Pulse from mahesh@benzinga.com

August 14, 2023 | 8:46 pm

LUNR

Intuitive Machines (NASDAQ:LUNR) reported Q2 sales of $17.99 million, a decrease of 6.37% from $19.22 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:46 pm

TIVC

Tivic Health Systems (NASDAQ:TIVC) reported Q2 losses of $(0.07) per share, beating the analyst consensus estimate of $(0.08) by 12.5%. However, the company's quarterly sales of $161.00K missed the analyst consensus estimate of $630.00K by 74.44%. This represents a 69.51% decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:46 pm

SNAL

Snail (NASDAQ:SNAL) reported Q2 losses of $(0.11) per share, missing the analyst consensus estimate of $0.07 by 257.14 percent. The company also reported quarterly sales of $9.89 million, missing the analyst consensus estimate of $22.48 million by 56.00 percent.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:43 pm

AEY

Addvantage Technologies (NASDAQ:AEY) reported Q2 losses of $(0.20) per share, a 81.82% decrease YoY. The company also reported a 49.12% decrease in sales to $12.09 million YoY.

Portfolio Pulse from mahesh@benzinga.com

August 14, 2023 | 8:43 pm